跳至主要内容
临床试验/NL-OMON31804
NL-OMON31804已完成4 期

Inflammatory Neuropathies: the Mechanism of Intravenous Immunoglobulin - Inflammatory Neuropathies and IVIg

niversitair Medisch Centrum Utrecht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age > 18 years
  • Patients with GBS. Patients with CIDP (exacerbation) and MMN who were not treated at least three months prior to inclusion.

排除标准

  • Other neuropathies (e.g. diabetic, porphiric, intoxication with medication or metal, vasculitic, Lyme neuroborreliosis, post-radiation, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies). Patients with an anaphylactic reaction to IVIg in the past.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验